The National Institutes of Health (NIH) has announced an upcoming funding opportunity, NOT-NS-24-021, under the National Institute of Neurological Disorders and Stroke (NINDS). This opportunity aims to support research in translational activities and small clinical studies for the development of therapeutic and diagnostic devices for disorders affecting the nervous or neuromuscular systems. The initiative is expected to be reissued from RFA-NS-21-021 and will utilize the R61/R33 activity code.
Eligibility for this funding spans a broad spectrum of applicants, including educational institutions, government entities, nonprofits, small businesses, and Native American tribal organizations. The main goal of this funding opportunity is to foster the advancement of low-risk devices that can significantly impact the treatment and diagnosis of neurological disorders. The announcement of this opportunity in Spring 2024, with an application due date in Summer 2024, provides potential applicants with ample time to develop meaningful collaborations and responsive projects. This initiative represents a crucial step in enhancing the treatment and diagnosis options available for disorders of the nervous and neuromuscular systems, reflecting NINDS’s commitment to driving innovation in neurological health.
Opportunity ID: 351120
General Information
| Document Type: | Grants Notice |
| Opportunity Number: | NOT-NS-24-021 |
| Opportunity Title: | Notice of Intent to Publish a Funding Opportunity Announcement for Translational Neural Devices (R61/R33 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | |
| Expected Number of Awards: | |
| CFDA Number(s): | |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 1 |
| Forecasted Date: | Nov 24, 2023 |
| Last Updated Date: | |
| Estimated Post Date: | Feb 22, 2024 |
| Estimated Application Due Date: | May 28, 2024 |
| Estimated Award Date: | Mar 01, 2025 |
| Estimated Project Start Date: | Mar 01, 2025 |
| Fiscal Year: | 2025 |
| Archive Date: | |
| Estimated Total Program Funding: | |
| Award Ceiling: | |
| Award Floor: |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Small businesses For profit organizations other than small businesses County governments State governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Private institutions of higher education Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice is to announce the intention of National Institutes of Neurological Disorders and Stroke (NINDS) to reissue RFA-NS-21-021 to solicit applications for research pursuing translational activities and small clinical studies to advance the development of low risk therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems.� This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.� The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. This NOFO will utilize the R61/R33 activity code. Details of the planned NOFO are provided below. |
| Link to Additional Information: | |
| Grantor Contact Information: |